JPS6143182A - Novel antibiotic ss19508d and preparation thereof - Google Patents

Novel antibiotic ss19508d and preparation thereof

Info

Publication number
JPS6143182A
JPS6143182A JP16367084A JP16367084A JPS6143182A JP S6143182 A JPS6143182 A JP S6143182A JP 16367084 A JP16367084 A JP 16367084A JP 16367084 A JP16367084 A JP 16367084A JP S6143182 A JPS6143182 A JP S6143182A
Authority
JP
Japan
Prior art keywords
antibiotic
ss19508d
strain
culture
novel antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP16367084A
Other languages
Japanese (ja)
Inventor
Masaru Matsumoto
勝 松本
Takemitsu Asaoka
浅岡 健光
Katsuhiko Nagaoka
克彦 長岡
Koichi Yokoi
横井 好一
Toshiaki Nakajima
中島 利章
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Priority to JP16367084A priority Critical patent/JPS6143182A/en
Publication of JPS6143182A publication Critical patent/JPS6143182A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NEW MATERIAL:An antibiotic SS19508D. Elementary analysis; C, 55.95; H, 3.50 (experimental values); C, 55,98; H.3.59 (theoretical values). Mass spectrum (EI70eV); M<+>m/z364. Molecular formula; C17H13O7Cl. Melting point: 193-196 deg.C. Specific rotary power {alpha}D<25>=+145 deg. (C=0.30, acetone), etc. USE:An antibiotic having improved antimicrobial activity against Grampositive bacteria and part of Gram-negative bacteria and trichophytons. PREPARATION:A strain having the ability to produce antibiotic SS19508D, e.g. Aspergillus terreus S19508 (FERM-P No. 7636) and a variant strain thereof or natural variant strain, is aerobically cultivated in a culture medium containing a nutrient source by the usual mold cultivation method to give the aimed antibiotic SS19508D having the structure expressed by, e.g. the formula.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は新規な抗生物質SS19508D及びその製造
法に関する。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a novel antibiotic SS19508D and a method for producing the same.

〔従来の技術〕[Conventional technology]

従来、微生物が生産する種々の抗生物質が仰られている
。
Conventionally, various antibiotics produced by microorganisms have been mentioned.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

本発明は医療用として有用な新規抗生物質を得ることを
目的とする。
The object of the present invention is to obtain a novel antibiotic useful for medical use.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者らは有用な抗生物質を見出す目的で天然の土壌
より数多くの微生物を単離し、その生産物について種々
研究を行なった。その結果、新潟県北蒲原郡水原町の土
壌から分離されたアスペルギルス属に属する微生物であ
るアスペルギルス テレウス(Aspergillus
terreus ) 819508 (微工研菌寄第7
636号)を培地中に培養すると、培養液中にダラム陽
性菌及び一部のダラム陰性菌並びに白癖菌に対し優れた
抗菌力を有する抗生物質5819508Bが生産される
ことを見出し、先に特許出願した(特願昭59−117
255号)。
The present inventors isolated a large number of microorganisms from natural soil and conducted various studies on their products in order to find useful antibiotics. As a result, Aspergillus terreus, a microorganism belonging to the Aspergillus genus, was isolated from the soil of Mizuhara-cho, Kitakanbara-gun, Niigata Prefecture.
terreus) 819508 (Microtechnical Laboratory No. 7
636) in a culture medium, it was discovered that antibiotic 5819508B, which has excellent antibacterial activity against Durum-positive bacteria, some Durum-negative bacteria, and Shirogensi bacteria, was produced in the culture solution, and the patent was granted earlier. I filed an application (patent application 117-1982).
No. 255).

本発明者らは更に研究を重ねた結果、上記アスペルギル
ス テレウス819508の培養液中に、抗生物質88
19508Bとは構造の異なる新規抗生物質SS195
08Dが存在することを見出し、本発明を完成した、 すなわち本発明は、新規な抗生物質5819508D及
びその製造法を提供するものである。
As a result of further research, the present inventors found that antibiotic 88 was added to the culture solution of Aspergillus terreus 819508.
SS195 is a new antibiotic with a different structure from 19508B.
The inventors discovered that 5819508D exists and completed the present invention. That is, the present invention provides a novel antibiotic 5819508D and a method for producing the same.

本発明の抗生物質SS19508Dを産生ずるアスペル
ギルス テレウス819508株は次のような菌学的性
質を有する。
Aspergillus terreus strain 819508, which produces the antibiotic SS19508D of the present invention, has the following mycological properties.

(a)  集落の性質 惺)各培地における生肯状帽 (])  生肯速朋 25℃では?テトデキストロース寒天培地、ツアペック
寒天培地における集落直径は夫々2.2Crn、2.0
cn1で生育抑制的であり、コーンミール寒天培地にお
ける集落直径は3.1 cmで生育やや速やかである。
(a) Characteristics of the colony) Is it normal for each culture medium at 25°C? The colony diameters on tetodextrose agar and Czapek agar were 2.2 Crn and 2.0 Crn, respectively.
cn1, the growth is suppressed, and the colony diameter on cornmeal agar medium is 3.1 cm, and the growth is rather rapid.

37℃では?テトデキストロース寒天培地、ツアペック
寒天培地における集落直径は夫々1、96Ra 2.4
cmで生育抑制的であり、コーンミール寒天培地におけ
る集落直径は1.1 cmで生育きわめて抑制的である
。
At 37℃? The colony diameters on tetodextrose agar and Czapek agar were 1 and 96Ra 2.4, respectively.
cm, and the colony diameter on cornmeal agar medium is 1.1 cm, which is extremely inhibiting growth.

(II)  生育ノQターン ■ ?テトデキストロース寒天培地 25℃では基底菌糸層はやや薄く、放射状の浅い溝を持
つ。淡かっ色〜茶かつ色でビロード状。分生子頭を多数
形成し分泌液は淡いこはく色。集落裏面は黄かつ色、3
7℃では基底菌糸+dは山岳状に高くもり上り、放射状
の浅い溝を持つ。茶かつ色で羊毛状。分生子頭を少し形
成し分泌液は濃いこはく色。集落裏面は濃赤かっ色。
(II) Growth Q-turn■? On tetodextrose agar medium at 25°C, the basal mycelial layer is rather thin and has shallow radial grooves. Pale brown to brown and velvety. Many conidial heads are formed and the secreted liquid is pale amber in color. The back side of the village is yellow and colored, 3
At 7°C, the basal hyphae +d rises high into a mountainous shape and has shallow radial grooves. Brown and woolly in color. A few conidial heads are formed and the secreted liquid is dark amber. The back side of the village is dark reddish-brown.

■ ツアペック寒天培地 25℃では基底菌糸層はやや薄く放射状の浅い時を持つ
。淡黄色〜淡かつ色でビロード状、分生子頭形成はやや
不足し分泌液はこはく色。果落鳩面は黄かつ色。37℃
では基底11糸肴は平たんで放射状の溝を待つ8淡黄色
〜淡かっ色で分生子頭形成はやや不足する。
■ At 25°C on Czapek agar medium, the basal mycelial layer is somewhat thin and has a shallow radial pattern. Pale yellow to pale and velvety in color, conidial head formation is somewhat lacking, and the secreted fluid is amber in color. The surface of the fruit drop is yellow and colored. 37℃
In this case, the basal 11 filaments are flat with radial grooves, 8 pale yellow to pale brown, and conidial head formation is somewhat lacking.

集v4裏面は黄かつ色。The back of the collection v4 is yellow and colored.

■ コーンミール寒天培地 25℃では基底菌糸層きわめて薄く平たん、はとんど無
色、所々にかつ色分生子頭が散在、集落裏面も無色。
■ On cornmeal agar medium at 25°C, the basal mycelial layer is extremely thin and flat, mostly colorless, with colored conidial heads scattered here and there, and the underside of the colony is also colorless.

(2)  生理的、生態的性質 ■ 生育至適温度 24〜35℃ ■ 生育の範囲 上記培地ではp)l 2. O〜12.0で生育するが
、好ましい生育範囲はpH4〜9である。
(2) Physiological and ecological properties ■ Optimum growth temperature 24-35°C ■ Growth range In the above medium, p) l 2. It grows at a pH of 0 to 12.0, but the preferred growth range is 4 to 9.

Φ) 顕微鏡的性質(分生子世代) ■ 分生子頭 円筒形〜長円筒形、赤かっ色〜青紫色、スライド培養で
は50〜150X40〜60μm 、。
Φ) Microscopic properties (conidial generation) ■ Conidial head cylindrical to oblong cylindrical, reddish-brown to bluish-purple, 50-150 x 40-60 μm in slide culture.

■ 分生子柄 ioo〜300X4〜6μm大部分は多少屈曲、滑面、
無色、先端が肥大して頂のうを形成。
■ Conidiophore ioo~300X4~6μm Most of it is slightly bent, smooth surface,
Colorless, the tip enlarges to form an apical capsule.

■ 頂のり 直径12〜16μmの半球形、上部的1/2よりメトレ
を生じ、生育途中のものは数本のメトレを生じ半球形に
は至らず。
■ The top has a hemispherical shape with a diameter of 12 to 16 μm, with metres appearing from the upper half, and those in the middle of growth have several metres and do not reach a hemispherical shape.

■ メトレ 5〜12x2〜3μm位、無色。■ Metre Approximately 5-12 x 2-3 μm, colorless.

■ フイアライド 6〜12×2〜3μm位、無色。メトレより1本あるい
は2本のフィアライドを生じる。
■ Fiallide 6-12 x 2-3 μm, colorless. One or two phialides are produced from metre.

■ 分生子 フイアライド塁分生子、長く連鎖、直径2〜3綿位、球
形、滑面。
■ Conidia phialide base conidia, long chains, 2-3 cotton diameter, spherical, smooth surface.

以上の集落及び顕微鏡的性質より本菌株を7スペルギル
ス テレウス(Aspergillusterreus
 )と同定した〇 本菌株はアスペルギルス テレウス819508(As
pergHlus terreus S 19508 
)と命名され、工業技術院微生物工業技術研究所に微工
研園寄第7636号(FEBMP−7636)として寄
託されている。
Based on the above-mentioned colonies and microscopic properties, this strain was identified as Aspergillus terreus.
) The strain identified as Aspergillus terreus 819508 (As
pergHlus terreus S 19508
) and has been deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology as FEBMP-7636.

なおアスペルギルス テレウスの一学的特徴は次の文献
、すなわち宇出用俊−1椿啓介ほか著:菌類図鑑、下巻
、1039〜1040頁、1978f−(g談社すイエ
ンティフイク)、C,Thorns M、 B、 Ch
urch : American Journalof
 Botany、 5巻、85頁、1918年に記載さ
れている。
The scientific characteristics of Aspergillus terreus can be found in the following documents: Shun Ude-1 Keisuke Tsubaki et al.: Illustrated Encyclopedia of Mycology, Volume 2, pp. 1039-1040, 1978f- (Gdansha Suientific), C. Thorns M, B, Ch
urch: American Journal of
Botany, vol. 5, p. 85, 1918.

本発明の抗生物質SS19508Dは上記函株を栄養源
含有培地に接種し、好気的に培養することにより製造さ
れる。抗生物質5s19508D生耗株としては上6[
5819508株はもとより、その人工変異株あるいは
自然食、 異株であっても、抗生物質SS19508D
を生産する舵力を有するものであればすべて本発明に使
用することができる。上記819508株の人工変異株
は、他のカビと同様、例えば紫外線、コバルト60照射
、化学変異誘導剤により容易に青ることかできる。
The antibiotic SS19508D of the present invention is produced by inoculating the above box strain into a nutrient-containing medium and culturing it aerobically. Antibiotic 5s19508D is the top 6 [
Not only the 5819508 strain, but also its artificial mutants, natural foods, and different strains can be used with the antibiotic SS19508D.
Any vehicle that has the steering force to produce can be used in the present invention. The artificial mutant strain 819508 can be easily turned blue by, for example, ultraviolet rays, cobalt-60 irradiation, or chemical mutagenic agents, like other molds.

次に抗生物質SS19508Dの装造法における醒株の
培養について説明する。すなわちアスペルギルス絹に属
する抗生物質SS19508D生並株の培aKは通常の
カビの培養法が用いられる。
Next, the cultivation of the Sengoku strain in the preparation method for the antibiotic SS19508D will be explained. That is, the culture aK of the antibiotic SS19508D fresh strain belonging to Aspergillus silk is prepared using a conventional mold culture method.

栄養培地としては、貧化しうる炭素源、窒素源、無機物
などを適当に含有する限抄、合成培地、半合成培地、あ
るいは天然培地のいづれでも使用可能である。炭素源と
しては、例えば、グルコース、デキストリン、デンプン
、ラクトース、サッカロース、クリセリン、糖蜜等が単
独または組合せて用いられる。さらに菌の資化性によっ
ては、炭化水素、アルコール類、有機酸等も用い得る、
窒素源としては、無機もしくは有機窒素化合物、例えば
、塩化アンモニウム、硫酸アンモニウム、硝酸アンモニ
ウム、尿素、グルタミン酸ナトリウム等、または天然物
、例えば、大豆抽出物、脱脂大豆、綿実粕、コーンステ
イープリカー、米ぬか、酵母エキス、ペゾトン、ソイト
ン等が単独または組合せて用いられる。抗生物質SS1
9508D生産菌の培養で抗生物質5819508pを
生産させる場合、必要とするときは、無機塩、金属塩を
加える。その他819508株の発育を助は抗生物質S
S19508Dの生産を促進する物質あるいはシリコン
油又はアデカノール(商品名)等の一般的消泡剤を適宜
培地に添加することもできる。
As the nutrient medium, any of limited extracts, synthetic media, semi-synthetic media, or natural media containing suitable carbon sources, nitrogen sources, inorganic substances, etc. that can be depleted can be used. As the carbon source, for example, glucose, dextrin, starch, lactose, sucrose, chrycerin, molasses, etc. are used alone or in combination. Furthermore, depending on the assimilation ability of the bacteria, hydrocarbons, alcohols, organic acids, etc. may also be used.
Nitrogen sources include inorganic or organic nitrogen compounds, such as ammonium chloride, ammonium sulfate, ammonium nitrate, urea, monosodium glutamate, etc., or natural products, such as soybean extract, defatted soybean, cottonseed meal, cornstap liquor, rice bran, etc. Yeast extract, pezoton, soyton, etc. may be used alone or in combination. Antibiotic SS1
When producing antibiotic 5819508p by culturing 9508D-producing bacteria, inorganic salts and metal salts are added if necessary. Antibiotic S helps the growth of other 819508 strains
A substance that promotes the production of S19508D or a general antifoaming agent such as silicone oil or Adekanol (trade name) can also be added to the medium as appropriate.

用養法としては、一般の抗生物質の生産に用いられる方
法が採用されるが、通常用いられる好気培養法、例えば
固体培養法、振盪培養法、通気攪拌培養法が好適に使用
され、特に通気攪拌培養法が最も適している。培養は好
気的条件下で行われ、培養に適当な温度は24〜35℃
であるが、一般に27℃付近で培養するのが好ましい。
As the cultivation method, methods used in the production of general antibiotics are adopted, but commonly used aerobic culture methods, such as solid culture method, shaking culture method, and aerated agitation culture method, are preferably used. The aerated agitation culture method is most suitable. Cultivation is carried out under aerobic conditions, and the appropriate temperature for cultivation is 24-35°C.
However, it is generally preferable to culture at around 27°C.

抗生物質8819508Dは、振盪培養、通気攪拌培養
の何れの場合も、その生産量は3〜5日間の培養で最高
に達する。培養液中の抗生物質S 819508 Dの
蓄積量が雫高に達した時に培養を停止し、培養液中から
目的物質を単離・精製する。培養液中からの抗生物質S
S19508Dの単離は、後記実施例に示す如く本抗生
物質の理化学的性状を考慮して種々の方法を単独で、あ
るいは適宜組合せることによって行われる。
The production amount of antibiotic 8819508D reaches its maximum after 3 to 5 days of culture in both shaking culture and aeration agitation culture. When the accumulated amount of antibiotic S 819508 D in the culture solution reaches a drop, the culture is stopped, and the target substance is isolated and purified from the culture solution. Antibiotic S from culture solution
Isolation of S19508D is carried out by using various methods alone or in appropriate combinations, taking into account the physicochemical properties of this antibiotic, as shown in Examples below.

すなわち、抗生物質SS19508Dは通常培養F液に
主に存在するので、培養液を遠心分離又は濾過等により
菌体を除去したのち、通常の分離手段、例えば各種溶媒
による抽出処理法、各種のイオン交換クロマトグラフ法
、種々の担体を用いたダル濾過法、吸層又は分配カラム
クロマトグラフ法、透析法、沈殿法等を適当に組み合せ
、また反復使用することKより培養液から抗生物質S 
S 19508Dを分離精製する。
That is, since the antibiotic SS19508D is mainly present in the normal culture solution F, after removing the bacterial cells from the culture solution by centrifugation or filtration, the normal separation means such as extraction treatment using various solvents, various ion exchange methods, etc. Antibiotic S can be extracted from the culture solution by appropriately combining chromatography methods, dull filtration methods using various carriers, absorption layer or partition column chromatography methods, dialysis methods, precipitation methods, etc., and by repeatedly using them.
Separate and purify S 19508D.

−好ましい分離精製法の例としては、次の方汗が績けら
れる。発酵を終了した培養液を遠心分離敵し、その上清
に適当な溶媒、例えば酢酸エチル等を加えて抽出する。
- Examples of preferred separation and purification methods include the following. After fermentation, the culture solution is centrifuged, and an appropriate solvent such as ethyl acetate is added to the supernatant for extraction.

得られた抽出液は硫酸ナトリウム等により脱水し減圧留
去後、残渣を不溶性溶剤、例えば石油エーテル咎で洗い
、その4Jpシリカグルカラムクロマトダクフイーに付
す。次に適当な溶離液、例えばクロロホルム等で溶出し
たのち活性画分を集め、減圧威硝後、残渣を適当な溶媒
、例えば丘−チルで再結晶すると抗生物質SS1950
8Dの微黄色結晶が得られる。
The obtained extract is dehydrated using sodium sulfate or the like and distilled off under reduced pressure. The residue is washed with an insoluble solvent such as petroleum ether and subjected to a 4Jp silica glu column chromatography. Next, after elution with an appropriate eluent such as chloroform, the active fractions are collected, and the residue is recrystallized with an appropriate solvent such as Oka-chill after distillation under reduced pressure.
8D pale yellow crystals are obtained.

以上の如くして得られた抗生物質SS19508Dは次
のような理化学的性質を有する。
The antibiotic SS19508D obtained as described above has the following physicochemical properties.

〈理化学的性質〉 ■ 元素分析 CH 実験値(%)  55.95 3.50理論値(%)5
5.98 3.59 ■ マススペクトル(EI70eV) M+ m/z  364 ■ 分子式 %式% 〔α〕B−+145°(C=0.30.アセトン)(リ
 紫外線吸収ス・くクトル 第11蛸 (リ 赤外ヤλ吸収スペクトル(KBr 法)第2図 ■ IH−毘スベクトル(90MHz )第3図 重クロロホルム浴液中TMsヲ基準物質として測定した
。
<Physical and chemical properties> ■ Elemental analysis CH Experimental value (%) 55.95 3.50 Theoretical value (%) 5
5.98 3.59 ■ Mass spectrum (EI70eV) M+ m/z 364 ■ Molecular formula % Formula % [α] B-+145° (C = 0.30. Acetone) Infrared λ absorption spectrum (KBr method) Fig. 2 IH-B spectrum (90 MHz) Fig. 3 TMs in heavy chloroform bath solution was measured as a reference material.

■ ”C−1’4Rスペクトル(22,5MHz )重
クロロホルム溶液中TMSを基準物質として測定した。
(2) "C-1'4R spectrum (22.5 MHz) Measured using TMS in deuterium chloroform solution as a reference substance.

δ(pprn) : 193.4 (8)、185.0
(8)、170.0(s)、168.6(g)、163
.3(B)、151.1(s)、149.5(s)、1
37.6(s)、137.2(d)、113.6(s)
、108.4 (s )、106.0 (d )、10
4.2(d)、84.6(8)、56.8 (q )、
5z、9(q)、22.0((1)6.91  溶解性 クロロホルム、ジメチルスルホキシド、酢酸エチルに可
溶。石油エーテル、n−ヘキサン、水に不溶。
δ(pprn): 193.4 (8), 185.0
(8), 170.0 (s), 168.6 (g), 163
.. 3(B), 151.1(s), 149.5(s), 1
37.6(s), 137.2(d), 113.6(s)
, 108.4 (s), 106.0 (d), 10
4.2(d), 84.6(8), 56.8(q),
5z, 9(q), 22.0 ((1) 6.91 Solubility Soluble in chloroform, dimethyl sulfoxide, ethyl acetate. Insoluble in petroleum ether, n-hexane, water.

■ 塩基性、酸性、中性の区別 弱酸性 @ 物質の色及び性状 微黄色結晶(エーテルより再結晶) 0 呈色反応 塩化第二鉄反応において陽性 0 薄層クロマトグラフィー 担体ニジリカゲルプレートF254 (メルク(+′ワ
 構造式 上記の理化学的測定値より、本発明の抗生物質SS19
508Dは下記構造式を有するものと決定した。
■ Distinguishing between basic, acidic, and neutral Weakly acidic @ Color and properties of the substance Slightly yellow crystals (recrystallized from ether) 0 Positive in color reaction ferric chloride reaction 0 Thin layer chromatography carrier Nijiri gel plate F254 (Merck (+'wa Structural formula From the above physical and chemical measurements, the antibiotic SS19 of the present invention
508D was determined to have the following structural formula.

〔作 用〕[For production]

く生物活性〉 抗圧物質SS19508Dの各種微生物に対する最小発
育阻止濃度(MIC”)を第1表に示す。
Biological Activity> Table 1 shows the minimum inhibitory concentration (MIC") of the anti-pressure substance SS19508D against various microorganisms.

第1表 次に実施例を挙げて説明する。Table 1 Next, an example will be given and explained.

実施例 ポテトスターチ2.0%、ファーマメディア2.0%、
コーンステイープリカー1.0%、炭酸カルシウム0.
3%の組成を有する液体培地をpH7,0とし、500
m7!各坂口フラスコに100−分注して滅菌する。こ
れにアスペルギルス テレウス819508株(*工研
菌を第7636号)を接種し、27℃で2日間振盪培養
して種培養液を作成する。同じ培地組成からなる液体培
地1.31を2.64答のゾヤーファメンターに仕込み
、これに前記の種培養液13−を接種し、培養温度27
℃、攪拌数35Orpm、通気量1.31! /分の条
件下で96時間培養を行う。次に培養液を3000rp
’nで10分間遠心分離するととKよ#)得られた上清
(900yd)を酢酸エチル1.8ノで4゜抽出し、こ
の酢酸エチル層を硫酸ナトリウムにより脱水したのち濃
・縮乾固した。この濃縮物を少量の石油エーテルにより
洗ったのち、シリカダル(メルク社製Kiesel G
el 60.230−400メツシユ)5fにまぶし、
あらかじめクロロホルムでノQツクしておいたシリカゲ
ルカラム(40f!tX500ml)K付し、クロロホ
ルムにより溶出した。まず抗生物質8819508Bが
溶出され、これとはよく分離して抗生物質581950
8Dが溶出されてぐる。
Example potato starch 2.0%, Pharmamedia 2.0%,
Corn staple liquor 1.0%, calcium carbonate 0.
A liquid medium with a composition of 3% was adjusted to pH 7.0 and 500
m7! Dispense 100 microliters into each Sakaguchi flask and sterilize. This was inoculated with Aspergillus terreus strain 819508 (*Koken Bacteria No. 7636) and cultured with shaking at 27°C for 2 days to prepare a seed culture. A liquid medium 1.31 consisting of the same medium composition was placed in a 2.64-liter Zoya fermenter, inoculated with the above seed culture solution 13-, and the culture temperature was increased to 27.
℃, stirring number 35 Orpm, aeration rate 1.31! Culture is carried out for 96 hours under the condition of /min. Next, rotate the culture solution at 3000 rpm.
After centrifugation for 10 minutes at 'n', the resulting supernatant (900 yd) was extracted with 1.8 mm of ethyl acetate at 4°C, and this ethyl acetate layer was dehydrated with sodium sulfate, concentrated and evaporated to dryness. did. After washing this concentrate with a small amount of petroleum ether, it was washed with silica dal (Kiesel G manufactured by Merck & Co.).
el 60.230-400 mesh) Sprinkle on 5f,
A silica gel column (40f!tX500ml) which had been pre-blocked with chloroform was loaded and eluted with chloroform. First, antibiotic 8819508B was eluted, and it was well separated from antibiotic 581950B.
8D was eluted.

この抗生物質SS19508D画分を集め、濃縮乾固し
たのち、少量のエーテルに溶かし再結晶させることによ
り、微黄色結晶として抗生物質SS19508Dを40
Mg得た。
The antibiotic SS19508D fractions were collected, concentrated to dryness, and then dissolved in a small amount of ether and recrystallized to obtain antibiotic SS19508D as pale yellow crystals.
I got Mg.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明の抗生物質SS19508Bの紫外線吸
収スペクトル、第2図は同赤外線吸収スペクトル、第3
図は同IH−NVII?、スペクトルである。 以上
Fig. 1 shows the ultraviolet absorption spectrum of the antibiotic SS19508B of the present invention, Fig. 2 shows its infrared absorption spectrum, and Fig. 3 shows the infrared absorption spectrum of the antibiotic SS19508B of the present invention.
Is the diagram the same IH-NVII? , is a spectrum. that's all

Claims (1)

【特許請求の範囲】 1、下記の理化学的性質を有する抗生物質SS1950
8D。 (1)元素分析        C     H 実験値(%) 55.95 3.50 理論値(%) 55.98 3.59 (2)マススペクトル(EI70eV) M^+m/z 364 (3)分子式 C_1_7H_1_3O_7Cl (4)融点 193〜196℃ (5)比旋光度 〔α〕^2^5_D=+145°(C=0.30、アセ
トン)(6)紫外線吸収スペクトル 第1図 λ^M^e^O^H_m_a_x(ε) 283nm(
16900)(7)赤外線吸収スペクトル(KBr法) 第2図 (8)^1H−NMRスペクトル(90MHz)第3図 重クロロホルム溶液中TMSを基準物質と して測定した。 (9)^1^3C−NMRスペクトル(22.5MHz
)重クロロホルム溶液中TMSを基準物質と して測定した。 δ(ppm):193.4(s)、185.0(s)、
170.0(s)、168.6(s)、163.3(s
)、151.1(s)、149.5(s)、137.6
(s)、137.2(d)、113.6(s)、108
.4(s)、106.0(d)、104.2(d)、8
4.6(s)、56.8(q)、52.9(q)、22
.0(q)(10)溶解性 クロロホルム、ジメチルスルホキシド、 酢酸エチルに可溶。石油エーテル、n− ヘキサン、水に不溶。 (11)塩基性、酸性、中性の区別 弱酸性 (12)物質の色及び性状 倣黄色結晶(エーテルより再結晶) (13)呈色反応 塩化第二鉄反応において陽性 (14)薄層クロマトグラフィー 担体:シリカゲルプレートF_2_5_4(メルク社製
) ▲数式、化学式、表等があります▼ 2、構造が次の式 ▲数式、化学式、表等があります▼ で表わされるものである特許請求の範囲第1項記載の新
規抗生物質SS19508D。 3、アスペルギルス属に属する新規抗生物質SS195
08D生産菌を培養し、その培養物から抗生物質SS1
9508Dを採取することを特徴とする新規抗生物質S
S19508Dの製造法。 4、SS19508D物質生産菌がアスペルギルステレ
ウスS19508株である特許請求の範囲第3項記載の
製造法。
[Claims] 1. Antibiotic SS1950 having the following physicochemical properties
8D. (1) Elemental analysis C H Experimental value (%) 55.95 3.50 Theoretical value (%) 55.98 3.59 (2) Mass spectrum (EI70eV) M^+m/z 364 (3) Molecular formula C_1_7H_1_3O_7Cl (4 ) Melting point: 193-196℃ (5) Specific optical rotation [α]^2^5_D=+145° (C=0.30, acetone) (6) Ultraviolet absorption spectrum Figure 1 λ^M^e^O^H_m_a_x ( ε) 283 nm (
16900) (7) Infrared absorption spectrum (KBr method) Figure 2 (8)^1H-NMR spectrum (90 MHz) Figure 3 Measurements were made using TMS in deuterium chloroform solution as a reference substance. (9)^1^3C-NMR spectrum (22.5MHz
) TMS in deuterated chloroform solution was used as a reference substance. δ (ppm): 193.4 (s), 185.0 (s),
170.0(s), 168.6(s), 163.3(s
), 151.1 (s), 149.5 (s), 137.6
(s), 137.2(d), 113.6(s), 108
.. 4(s), 106.0(d), 104.2(d), 8
4.6(s), 56.8(q), 52.9(q), 22
.. 0(q)(10) Solubility Soluble in chloroform, dimethyl sulfoxide, ethyl acetate. Insoluble in petroleum ether, n-hexane, and water. (11) Distinguishing between basic, acidic, and neutral Weakly acidic (12) Yellow crystals imitating the color and properties of substances (recrystallized from ether) (13) Positive in color reaction ferric chloride reaction (14) Thin layer chromatography Graphic carrier: Silica gel plate F_2_5_4 (manufactured by Merck & Co.) ▲Contains mathematical formulas, chemical formulas, tables, etc.▼ 2. Claim 1 whose structure is represented by the following formula ▲Contains mathematical formulas, chemical formulas, tables, etc.▼ Novel antibiotic SS19508D described in Section 1. 3. SS195, a novel antibiotic belonging to the Aspergillus genus
08D-producing bacteria were cultured, and antibiotic SS1 was obtained from the culture.
Novel antibiotic S characterized by collecting 9508D
Manufacturing method of S19508D. 4. The production method according to claim 3, wherein the SS19508D substance-producing bacterium is Aspergillus terreus S19508 strain.
JP16367084A 1984-08-03 1984-08-03 Novel antibiotic ss19508d and preparation thereof Pending JPS6143182A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16367084A JPS6143182A (en) 1984-08-03 1984-08-03 Novel antibiotic ss19508d and preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16367084A JPS6143182A (en) 1984-08-03 1984-08-03 Novel antibiotic ss19508d and preparation thereof

Publications (1)

Publication Number Publication Date
JPS6143182A true JPS6143182A (en) 1986-03-01

Family

ID=15778358

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16367084A Pending JPS6143182A (en) 1984-08-03 1984-08-03 Novel antibiotic ss19508d and preparation thereof

Country Status (1)

Country Link
JP (1) JPS6143182A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007512238A (en) * 2003-10-31 2007-05-17 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 2-Phenyl-benzofuran derivative, process for its production and use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007512238A (en) * 2003-10-31 2007-05-17 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 2-Phenyl-benzofuran derivative, process for its production and use thereof
JP4758905B2 (en) * 2003-10-31 2011-08-31 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 2-Phenyl-benzofuran derivative, process for its production and use thereof

Similar Documents

Publication Publication Date Title
CA2085522A1 (en) Microbial process for the production of trans-4-hydroxy-l-proline
US4550021A (en) Antitumor antibiotic 81-484 and process for its production
US4940582A (en) Antibiotic YI-HU3
JP4380913B2 (en) Novel FT-0554 substance and production method thereof
JPS60260570A (en) Novel antibiotic substance ss19508b and its preparation
JPS6015318B2 (en) New antibiotic SF-1942 substance, its manufacturing method and anticancer agent containing it
JPH05170769A (en) New compound q-11270 or its production
KR810000686B1 (en) Process for the preparation of piperidine derivative
JPH0625095B2 (en) Antibiotic SF-2415 substance and its production method
JPS6348284A (en) Novel antibiotic yp-02908l-a and production thereof
JPH0338274B2 (en)
JPS61274693A (en) Novel antibiotic ss21020c and production thereof
JPH04360894A (en) Fo-1513a substance and production thereof
JPS62149693A (en) Antibiotic substance ss42227b and production thereof
JPS6135788A (en) Physiologically active substance ss20846a and its preparation
JPH03197477A (en) Substances fo-608b and c and its production
JPH0259596A (en) Novel substance, utilization and production thereof
JPS62228074A (en) Substance ss50408 and production thereof
JPS61151149A (en) Differanisole a and its preparation
JPH0680607A (en) Malbranicin
JPS6269992A (en) Antibiotic ss42227a and production thereof
JPS61152295A (en) Novel antibiotic ss46506a and its preparation
JPS6265692A (en) Production of leptomycin a
JPS6167492A (en) Novel antibiotic substance ss21020a and its preparation
JPH0349687A (en) New anti-tumor antibiotic resolutiomycin and its production method